Regulatory impasse leaves libido-boosting 'female Viagra' in limbo Add to ...

SHARE

Replay
AP Video |
Show Description
The FDA rejected a drug that is meant to boost a woman's libido. Sprout Pharmaceuticals says it's at an impasse with the agency over the company's pink pill, Flibanserin, leaving the 15-year search for a 'female Viagra' in limbo

More from this section

Most Popular

Editor's Picks

Globe Shows »

Careers
Put your best foot forward with our expert advice